Automated virtual care and communication platform Conversa increased its Series B financing round Jan. 19 to $20 million, up from $12 million last June, led by Northwell Health's venture arm.
Northwell Health Ventures co-led Conversa's Series B funding round alongside Builders VC in June 2020. The New Hyde Park, N.Y.-based health system deployed Conversa's platform last year to help with its COVID-19 response. Conversa's platform offers automated chatbots to engage, monitor and manage patients for care conditions and services including COVID-19, chronic care, acute discharge, perioperative and oncology.
Other investors in Conversa include UH Ventures — the venture arm of Cleveland-based University Hospitals — P5 Health Ventures, Genesis Merchant Capital, J-Ventures, Epic Ventures, StartUp Health and Nassau Street Ventures, according to the release.
Conversa will use the additional $8 million to scale its tech platform and expand its automated virtual care digital tools. To date, the company has raised $34 million.
Editor's note: This article was updated at 1 p.m. CST on Jan. 20.
More articles on digital transformation:
Harvard, MIT and Boston-area hospitals get $76M for health innovation center
Mayo Clinic, Microsoft, Epic and more join forces to improve digital COVID-19 vaccination records
CVS Health launches voice-powered home care monitoring platform: 4 things to know